Assembly Biosciences, Inc. (ASMB)
22.19
-0.31
(-1.38%)
USD |
NASDAQ |
Nov 20, 16:00
22.26
+0.07
(+0.32%)
After-Hours: 20:00
Assembly Biosciences Price to Book Value : 1.513 for Nov. 20, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2026 | 1.513 |
| November 19, 2026 | 1.534 |
| November 18, 2026 | 1.526 |
| November 17, 2026 | 1.534 |
| November 16, 2026 | 1.451 |
| November 13, 2026 | 1.440 |
| November 12, 2026 | 1.376 |
| November 11, 2026 | 1.525 |
| November 10, 2026 | 1.455 |
| November 09, 2026 | 1.485 |
| November 06, 2026 | 1.392 |
| November 05, 2026 | 1.363 |
| November 04, 2026 | 1.354 |
| November 03, 2026 | 1.358 |
| November 02, 2026 | 1.33 |
| October 30, 2026 | 1.372 |
| October 29, 2026 | 1.422 |
| October 28, 2026 | 1.402 |
| October 27, 2026 | 1.384 |
| October 26, 2026 | 1.341 |
| October 23, 2026 | 1.352 |
| October 22, 2026 | 1.382 |
| October 21, 2026 | 1.395 |
| October 20, 2026 | 1.444 |
| October 19, 2026 | 1.374 |
| Date | Value |
|---|---|
| October 16, 2026 | 1.370 |
| October 15, 2026 | 1.402 |
| October 14, 2026 | 1.400 |
| October 13, 2026 | 1.387 |
| October 12, 2026 | 1.552 |
| October 09, 2026 | 1.604 |
| October 08, 2026 | 1.556 |
| October 07, 2026 | 1.564 |
| October 06, 2026 | 1.512 |
| October 05, 2026 | 1.550 |
| October 02, 2026 | 1.536 |
| October 01, 2026 | 1.566 |
| September 30, 2026 | 1.601 |
| September 29, 2026 | 1.525 |
| September 28, 2026 | 1.533 |
| September 25, 2026 | 1.537 |
| September 24, 2026 | 1.537 |
| September 23, 2026 | 1.557 |
| September 22, 2026 | 1.653 |
| September 21, 2026 | 1.652 |
| September 18, 2026 | 1.622 |
| September 17, 2026 | 1.646 |
| September 16, 2026 | 1.655 |
| September 15, 2026 | 1.696 |
| September 14, 2026 | 1.881 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Gilead Sciences, Inc. | 15.84 |
| ACADIA Pharmaceuticals, Inc. | 2.131 |
| Alnylam Pharmaceuticals, Inc. | 5.343 |
| Anika Therapeutics, Inc. | 1.288 |
| Savara, Inc. | 8.118 |
Price to Book Value Related Metrics
| PS Ratio | 6.076 |
| Price | 22.19 |
| Earnings Yield | -1.26% |
| Market Cap | 451.97M |